Lonza Group Ltd
LO3
Company Profile
Business description
Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
Contact
Muenchensteinerstrasse 38
Basel4002
CHET: +41 613168111
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
18,686
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,777.90 | 50.80 | -0.58% |
CAC 40 | 7,877.66 | 110.95 | 1.43% |
DAX 40 | 24,562.44 | 355.53 | 1.47% |
Dow JONES (US) | 44,240.76 | 165.60 | -0.37% |
FTSE 100 | 8,860.32 | 6.14 | 0.07% |
HKSE | 23,892.32 | 255.75 | -1.06% |
NASDAQ | 20,418.46 | 5.95 | 0.03% |
Nikkei 225 | 39,821.28 | 132.47 | 0.33% |
NZX 50 Index | 12,768.61 | 90.41 | -0.70% |
S&P 500 | 6,225.52 | 0.00 | 0.00% |
S&P/ASX 200 | 8,538.60 | 52.10 | -0.61% |
SSE Composite Index | 3,493.05 | 4.43 | -0.13% |